Ayusin ang sukat ng screen
Resize out
Resize in
Resize I-reset
Done Tapos na
CureVac - Ingmar Hoerr, CEO

CureVac - Ingmar Hoerr, CEO

Pinanood ng 1,211 beses

Pagpapatunay ng katauhan

8.1
Salamat, ang boto mo ay nairekord na at malapit ng makita.
Oo
Hindi
Paglalarawan ng bidyo:

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

Mga Komento